Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
NCO-48 fumarate (2 trials)
tenofovir alafenamide (genvoya) (1 trial)
Hepatitis (Phase 1)
Hepatitis A (Phase 1)
Hepatitis B (Phase 1)
Hepatitis B, Chronic (Phase 1)
Hepatitis, Chronic (Phase 1)
Trials (2 total)
Trial APIs (2 total)